Format

Send to

Choose Destination
See comment in PubMed Commons below
ScientificWorldJournal. 2011 May 26;11:1103-12. doi: 10.1100/tsw.2011.104.

Current and emerging bladder cancer urinary biomarkers.

Author information

1
Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA. jparker1@health.usf.edu

Abstract

Bladder cancer continues to be one of the most common malignancies. Those who have been already diagnosed are at high risk for recurrence, especially if the pathology demonstrates high-grade disease. Diagnosis and surveillance is reliant on invasive evaluation with cystoscopy. Urinary cytology has been used to aid in diagnosis, but its use is limited. Other assays have been developed that may aid in clinical decision making. The ultimate goal will be the development of a highly sensitive and specific urinary marker for bladder cancer. This would provide a noninvasive means of diagnosing the disease and limit the number of unnecessary cystoscopies. This article will review the currently available urinary bladder cancer markers. It will also review new and investigational urinary markers that have shown promise for future clinical use.

PMID:
21623456
PMCID:
PMC5720052
DOI:
10.1100/tsw.2011.104
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Hindawi Publishing Corporation Icon for PubMed Central
    Loading ...
    Support Center